Prognostic Model of TAC in the Treatment of MN
Condition: Idiopathic Membranous Nephropathy Intervention: Drug: Tacrolimus Sponsor: Qianfoshan Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2022 Category: Research Source Type: clinical trials
Prognostic Model of GC/TAC in the Treatment of MN
Condition: Idiopathic Membranous Nephropathy Intervention: Drug: glucocorticoid + tacrolimus Sponsor: Qianfoshan Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2022 Category: Research Source Type: clinical trials
Prognostic Model of TAC in the Treatment of MN
Condition: Idiopathic Membranous Nephropathy Intervention: Drug: Tacrolimus Sponsor: Qianfoshan Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2022 Category: Research Source Type: clinical trials
Prognostic Model of GC/TAC in the Treatment of MN
Condition: Idiopathic Membranous Nephropathy Intervention: Drug: glucocorticoid + tacrolimus Sponsor: Qianfoshan Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2022 Category: Research Source Type: clinical trials
Prognostic Model of TAC in the Treatment of MN
Condition: Idiopathic Membranous Nephropathy Intervention: Drug: Tacrolimus Sponsor: Qianfoshan Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2022 Category: Research Source Type: clinical trials
Prognostic Model of GC/TAC in the Treatment of MN
Condition: Idiopathic Membranous Nephropathy Intervention: Drug: glucocorticoid + tacrolimus Sponsor: Qianfoshan Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2022 Category: Research Source Type: clinical trials
Prognostic Model of TAC in the Treatment of MN
Condition: Idiopathic Membranous Nephropathy Intervention: Drug: Tacrolimus Sponsor: Qianfoshan Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2022 Category: Research Source Type: clinical trials
Prognostic Model of GC/TAC in the Treatment of MN
Condition: Idiopathic Membranous Nephropathy Intervention: Drug: glucocorticoid + tacrolimus Sponsor: Qianfoshan Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2022 Category: Research Source Type: clinical trials
Prognostic Model of TAC in the Treatment of MN
Condition: Idiopathic Membranous Nephropathy Intervention: Drug: Tacrolimus Sponsor: Qianfoshan Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2022 Category: Research Source Type: clinical trials